Global Promacta Market Growth 2022-2028
- LP 4817818
- 72 Pages
- February 2022
- Pharmaceuticals
The United States Promacta market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Promacta market, reaching US$ million by the year 2028. As for the Europe Promacta landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Promacta players cover Novartis Pharmaceuticals, , , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Promacta market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
25mg
50mg
75mg
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Drugs Stores
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Novartis Pharmaceuticals
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Promacta Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Promacta by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Promacta by Country/Region, 2017, 2022 & 2028
2.2 Promacta Segment by Type
2.2.1 25mg
2.2.2 50mg
2.2.3 75mg
2.3 Promacta Sales by Type
2.3.1 Global Promacta Sales Market Share by Type (2017-2022)
2.3.2 Global Promacta Revenue and Market Share by Type (2017-2022)
2.3.3 Global Promacta Sale Price by Type (2017-2022)
2.4 Promacta Segment by Application
2.4.1 Hospital
2.4.2 Drugs Stores
2.4.3 Other
2.5 Promacta Sales by Application
2.5.1 Global Promacta Sale Market Share by Application (2017-2022)
2.5.2 Global Promacta Revenue and Market Share by Application (2017-2022)
2.5.3 Global Promacta Sale Price by Application (2017-2022)
3 Global Promacta by Company
3.1 Global Promacta Breakdown Data by Company
3.1.1 Global Promacta Annual Sales by Company (2020-2022)
3.1.2 Global Promacta Sales Market Share by Company (2020-2022)
3.2 Global Promacta Annual Revenue by Company (2020-2022)
3.2.1 Global Promacta Revenue by Company (2020-2022)
3.2.2 Global Promacta Revenue Market Share by Company (2020-2022)
3.3 Global Promacta Sale Price by Company
3.4 Key Manufacturers Promacta Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Promacta Product Location Distribution
3.4.2 Players Promacta Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Promacta by Geographic Region
4.1 World Historic Promacta Market Size by Geographic Region (2017-2022)
4.1.1 Global Promacta Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Promacta Annual Revenue by Geographic Region
4.2 World Historic Promacta Market Size by Country/Region (2017-2022)
4.2.1 Global Promacta Annual Sales by Country/Region (2017-2022)
4.2.2 Global Promacta Annual Revenue by Country/Region
4.3 Americas Promacta Sales Growth
4.4 APAC Promacta Sales Growth
4.5 Europe Promacta Sales Growth
4.6 Middle East & Africa Promacta Sales Growth
5 Americas
5.1 Americas Promacta Sales by Country
5.1.1 Americas Promacta Sales by Country (2017-2022)
5.1.2 Americas Promacta Revenue by Country (2017-2022)
5.2 Americas Promacta Sales by Type
5.3 Americas Promacta Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Promacta Sales by Region
6.1.1 APAC Promacta Sales by Region (2017-2022)
6.1.2 APAC Promacta Revenue by Region (2017-2022)
6.2 APAC Promacta Sales by Type
6.3 APAC Promacta Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Promacta by Country
7.1.1 Europe Promacta Sales by Country (2017-2022)
7.1.2 Europe Promacta Revenue by Country (2017-2022)
7.2 Europe Promacta Sales by Type
7.3 Europe Promacta Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Promacta by Country
8.1.1 Middle East & Africa Promacta Sales by Country (2017-2022)
8.1.2 Middle East & Africa Promacta Revenue by Country (2017-2022)
8.2 Middle East & Africa Promacta Sales by Type
8.3 Middle East & Africa Promacta Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Promacta
10.3 Manufacturing Process Analysis of Promacta
10.4 Industry Chain Structure of Promacta
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Promacta Distributors
11.3 Promacta Customer
12 World Forecast Review for Promacta by Geographic Region
12.1 Global Promacta Market Size Forecast by Region
12.1.1 Global Promacta Forecast by Region (2023-2028)
12.1.2 Global Promacta Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Promacta Forecast by Type
12.7 Global Promacta Forecast by Application
13 Key Players Analysis
13.1 Novartis Pharmaceuticals
13.1.1 Novartis Pharmaceuticals Company Information
13.1.2 Novartis Pharmaceuticals Promacta Product Offered
13.1.3 Novartis Pharmaceuticals Promacta Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Novartis Pharmaceuticals Main Business Overview
13.1.5 Novartis Pharmaceuticals Latest Developments
14 Research Findings and Conclusion
Table 1. Promacta Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Promacta Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 25mg
Table 4. Major Players of 50mg
Table 5. Major Players of 75mg
Table 6. Global Promacta Sales by Type (2017-2022) & (K MT)
Table 7. Global Promacta Sales Market Share by Type (2017-2022)
Table 8. Global Promacta Revenue by Type (2017-2022) & ($ million)
Table 9. Global Promacta Revenue Market Share by Type (2017-2022)
Table 10. Global Promacta Sale Price by Type (2017-2022) & (USD/MT)
Table 11. Global Promacta Sales by Application (2017-2022) & (K MT)
Table 12. Global Promacta Sales Market Share by Application (2017-2022)
Table 13. Global Promacta Revenue by Application (2017-2022)
Table 14. Global Promacta Revenue Market Share by Application (2017-2022)
Table 15. Global Promacta Sale Price by Application (2017-2022) & (USD/MT)
Table 16. Global Promacta Sales by Company (2020-2022) & (K MT)
Table 17. Global Promacta Sales Market Share by Company (2020-2022)
Table 18. Global Promacta Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Promacta Revenue Market Share by Company (2020-2022)
Table 20. Global Promacta Sale Price by Company (2020-2022) & (USD/MT)
Table 21. Key Manufacturers Promacta Producing Area Distribution and Sales Area
Table 22. Players Promacta Products Offered
Table 23. Promacta Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Promacta Sales by Geographic Region (2017-2022) & (K MT)
Table 27. Global Promacta Sales Market Share Geographic Region (2017-2022)
Table 28. Global Promacta Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Promacta Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Promacta Sales by Country/Region (2017-2022) & (K MT)
Table 31. Global Promacta Sales Market Share by Country/Region (2017-2022)
Table 32. Global Promacta Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Promacta Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Promacta Sales by Country (2017-2022) & (K MT)
Table 35. Americas Promacta Sales Market Share by Country (2017-2022)
Table 36. Americas Promacta Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Promacta Revenue Market Share by Country (2017-2022)
Table 38. Americas Promacta Sales by Type (2017-2022) & (K MT)
Table 39. Americas Promacta Sales Market Share by Type (2017-2022)
Table 40. Americas Promacta Sales by Application (2017-2022) & (K MT)
Table 41. Americas Promacta Sales Market Share by Application (2017-2022)
Table 42. APAC Promacta Sales by Region (2017-2022) & (K MT)
Table 43. APAC Promacta Sales Market Share by Region (2017-2022)
Table 44. APAC Promacta Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Promacta Revenue Market Share by Region (2017-2022)
Table 46. APAC Promacta Sales by Type (2017-2022) & (K MT)
Table 47. APAC Promacta Sales Market Share by Type (2017-2022)
Table 48. APAC Promacta Sales by Application (2017-2022) & (K MT)
Table 49. APAC Promacta Sales Market Share by Application (2017-2022)
Table 50. Europe Promacta Sales by Country (2017-2022) & (K MT)
Table 51. Europe Promacta Sales Market Share by Country (2017-2022)
Table 52. Europe Promacta Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Promacta Revenue Market Share by Country (2017-2022)
Table 54. Europe Promacta Sales by Type (2017-2022) & (K MT)
Table 55. Europe Promacta Sales Market Share by Type (2017-2022)
Table 56. Europe Promacta Sales by Application (2017-2022) & (K MT)
Table 57. Europe Promacta Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Promacta Sales by Country (2017-2022) & (K MT)
Table 59. Middle East & Africa Promacta Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Promacta Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Promacta Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Promacta Sales by Type (2017-2022) & (K MT)
Table 63. Middle East & Africa Promacta Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Promacta Sales by Application (2017-2022) & (K MT)
Table 65. Middle East & Africa Promacta Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Promacta
Table 67. Key Market Challenges & Risks of Promacta
Table 68. Key Industry Trends of Promacta
Table 69. Promacta Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Promacta Distributors List
Table 72. Promacta Customer List
Table 73. Global Promacta Sales Forecast by Region (2023-2028) & (K MT)
Table 74. Global Promacta Sales Market Forecast by Region
Table 75. Global Promacta Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Promacta Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Promacta Sales Forecast by Country (2023-2028) & (K MT)
Table 78. Americas Promacta Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Promacta Sales Forecast by Region (2023-2028) & (K MT)
Table 80. APAC Promacta Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Promacta Sales Forecast by Country (2023-2028) & (K MT)
Table 82. Europe Promacta Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Promacta Sales Forecast by Country (2023-2028) & (K MT)
Table 84. Middle East & Africa Promacta Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Promacta Sales Forecast by Type (2023-2028) & (K MT)
Table 86. Global Promacta Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Promacta Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Promacta Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Promacta Sales Forecast by Application (2023-2028) & (K MT)
Table 90. Global Promacta Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Promacta Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Promacta Revenue Market Share Forecast by Application (2023-2028)
Table 93. Novartis Pharmaceuticals Basic Information, Promacta Manufacturing Base, Sales Area and Its Competitors
Table 94. Novartis Pharmaceuticals Promacta Product Offered
Table 95. Novartis Pharmaceuticals Promacta Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 96. Novartis Pharmaceuticals Main Business
Table 97. Novartis Pharmaceuticals Latest Developments
List of Figures
Figure 1. Picture of Promacta
Figure 2. Promacta Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Promacta Sales Growth Rate 2017-2028 (K MT)
Figure 7. Global Promacta Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Promacta Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 25mg
Figure 10. Product Picture of 50mg
Figure 11. Product Picture of 75mg
Figure 12. Global Promacta Sales Market Share by Type in 2021
Figure 13. Global Promacta Revenue Market Share by Type (2017-2022)
Figure 14. Promacta Consumed in Hospital
Figure 15. Global Promacta Market: Hospital (2017-2022) & (K MT)
Figure 16. Promacta Consumed in Drugs Stores
Figure 17. Global Promacta Market: Drugs Stores (2017-2022) & (K MT)
Figure 18. Promacta Consumed in Other
Figure 19. Global Promacta Market: Other (2017-2022) & (K MT)
Figure 20. Global Promacta Sales Market Share by Application (2017-2022)
Figure 21. Global Promacta Revenue Market Share by Application in 2021
Figure 22. Promacta Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Promacta Revenue Market Share by Company in 2021
Figure 24. Global Promacta Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Promacta Revenue Market Share by Geographic Region in 2021
Figure 26. Global Promacta Sales Market Share by Region (2017-2022)
Figure 27. Global Promacta Revenue Market Share by Country/Region in 2021
Figure 28. Americas Promacta Sales 2017-2022 (K MT)
Figure 29. Americas Promacta Revenue 2017-2022 ($ Millions)
Figure 30. APAC Promacta Sales 2017-2022 (K MT)
Figure 31. APAC Promacta Revenue 2017-2022 ($ Millions)
Figure 32. Europe Promacta Sales 2017-2022 (K MT)
Figure 33. Europe Promacta Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Promacta Sales 2017-2022 (K MT)
Figure 35. Middle East & Africa Promacta Revenue 2017-2022 ($ Millions)
Figure 36. Americas Promacta Sales Market Share by Country in 2021
Figure 37. Americas Promacta Revenue Market Share by Country in 2021
Figure 38. United States Promacta Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Promacta Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Promacta Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Promacta Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Promacta Sales Market Share by Region in 2021
Figure 43. APAC Promacta Revenue Market Share by Regions in 2021
Figure 44. China Promacta Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Promacta Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Promacta Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Promacta Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Promacta Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Promacta Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Promacta Sales Market Share by Country in 2021
Figure 51. Europe Promacta Revenue Market Share by Country in 2021
Figure 52. Germany Promacta Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Promacta Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Promacta Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Promacta Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Promacta Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Promacta Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Promacta Revenue Market Share by Country in 2021
Figure 59. Egypt Promacta Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Promacta Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Promacta Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Promacta Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Promacta Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Promacta in 2021
Figure 65. Manufacturing Process Analysis of Promacta
Figure 66. Industry Chain Structure of Promacta
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
